ArticleHeliyon2024
Practice of distributed machine learning in clinical modeling for chronic obstructive pulmonary disease.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in artificial intelligence applications for the management of chronic obstructive pulmonary disease.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The high prevalence, morbidity and mortality, and disease heterogeneity of chronic obstructive pulmonary disease (COPD) result in the scattered data derived from patient visits in different medical units. The huge cost of integrating the scattered data for analysis and modeling, as well as the legal demand for patient privacy protection lead to the emergence of data island. Objectives: On the premise of protecting patient privacy, integrating scattered data of patients from different medical units for high-quality modeling is beneficial to promoting the development of digital health. Based on this, we develop a distributed COPD disease diagnosis system termed COPD average federated learning (COPD_AVG_FL) using FedAvg. Methods: First, to build the COPD_AVG_FL, the clinical data of COPD patients from the real world is collected and the data pre-processing is performed to clean the incorrect data, outlier samples and missing values. Then, a classical federated learning architecture is designed as COPD_AVG_FL. Finally, to evaluate the established COPD_AVG_FL system, we develop Centralized Machine Learning (CML). Conclusions: Our results suggest that, with the assistance of COPD_AVG_FL, the absolute improvement rates are 13.4% (accuracy), 13.3% (precision), 12.8% (recall), 13.1% (F1-Score) and 12.9% (AUC) on the test data, respectively. The decoupling between model training and raw training data protects the patients' privacy, and helps to securely integrate more COPD data from different medical units to generate a more comprehensive model COPD_AVG_FL. This approach promotes the landing of wise information technology of medicine for COPD in the real clinical world. Code for our model will be made available at https://github.com/Cczhh/COPD_AVG_FL/tree/master.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.